摩根士丹利开始对Ovintiv进行报道,并将其评为"重量平等",目标价格为68美元. Morgan Stanley initiates coverage of Ovintiv with an "equal weight" rating and $68 price target.

摩根士丹利开始对Ovintiv进行报道,并给出了"同等权重"评级和68美元的目标价格,预测将近9%上. Morgan Stanley initiated coverage of Ovintiv with an "equal weight" rating and an $68.00 price target, predicting nearly 9% upside. 其他分析师则看好高盛升级为"买入", 加拿大皇家银行保持"超强"评级. Other analysts are bullish, with Goldman Sachs upgrading to a "buy" and Royal Bank of Canada maintaining an "outperform" rating. 尽管内部人士已经出售股票, 但Ovintiv最近报告的收益强超过预期. Ovintiv recently reported strong earnings beating expectations, though insiders have sold shares.